Bausch Health Companies (BHC) Capital Expenditures (2009 - 2026)

Bausch Health Companies has disclosed Capital Expenditures across 18 years of filings, most recently posting $109.0 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $109.0 million, down 5.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $391.0 million (up 5.68% YoY), and the FY2025 annual result was $397.0 million, up 17.8% from the prior year.
• Capital Expenditures came in at $109.0 million for Q1 2026 at Bausch Health Companies, up from $92.0 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $115.0 million in Q1 2025 to a low of $28.0 million in Q2 2023.
• The 5-year median for Capital Expenditures is $78.0 million (2024), against an average of $75.1 million.
• Across the five-year window, Capital Expenditures slumped 46.15% in 2023 and surged 178.57% in 2024, its largest moves.
• Bausch Health Companies' Capital Expenditures stood at $66.0 million in 2022, then jumped by 48.48% to $98.0 million in 2023, then rose by 8.16% to $106.0 million in 2024, then decreased by 13.21% to $92.0 million in 2025, then advanced by 18.48% to $109.0 million in 2026.
• The last three Capital Expenditures figures came in at $109.0 million (Q1 2026), $92.0 million (Q4 2025), and $91.0 million (Q3 2025), per Business Quant data.